114 related articles for article (PubMed ID: 6715085)
1. Long-term treatment of arterial hypertension with verapamil.
Wigler I; Peer G; Soferman G; Blum M; Aviram A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):162-6. PubMed ID: 6715085
[TBL] [Abstract][Full Text] [Related]
2. [Use of isoptin SR-240 in treatment of hypertension].
Knypl K; Brym E; Wacławek-Maczkowska J
Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
4. [Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension].
Hergueta García de Guadiana G; Paumard Fraguas A
An Med Interna; 1989 Jan; 6(1):15-8. PubMed ID: 2491026
[TBL] [Abstract][Full Text] [Related]
5. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with verapamil and nitrendipine in patients with hypertension.
Nalbantgil I; Onder R; Kiliçcioğlu B; Türkoğlu C
J Hum Hypertens; 1993 Jun; 7(3):305-8. PubMed ID: 8345499
[TBL] [Abstract][Full Text] [Related]
7. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
[TBL] [Abstract][Full Text] [Related]
9. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
[TBL] [Abstract][Full Text] [Related]
10. [A comparison and synergy in the treatment of essential arterial hypertension].
Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerrero MI; Flores Serrano AG; González Franco MF
Arch Inst Cardiol Mex; 1993; 63(2):133-7. PubMed ID: 8503714
[TBL] [Abstract][Full Text] [Related]
11. [Plasma levels and noninvasive hemodynamic profile of slow release verapamil (240 mg). A multicenter study].
Vulpis V; Seccia TM; Ricci S; Pirrelli A
Riv Eur Sci Med Farmacol; 1993; 15(5-6):227-35. PubMed ID: 7761676
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy.
Rubio-Guerra AF; Lozano-Nuevo JJ; Vargas-Ayala G; Rodríguez-López L; Ramos-Brizuela LM; Escalante-Acosta BA
Clin Exp Hypertens; 2006 Oct; 28(7):619-24. PubMed ID: 17060060
[TBL] [Abstract][Full Text] [Related]
13. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
15. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
[TBL] [Abstract][Full Text] [Related]
17. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hypertension with a fixed calcium antagonist-diuretic combination. Observations from treatment of 5,595 patients].
Klaus D
Fortschr Med; 1995 Mar; 113(7):90-6. PubMed ID: 7750891
[TBL] [Abstract][Full Text] [Related]
19. The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effects.
Yagil Y; Leibel B; Kobrin I; Stessman J; Ishay DB
Postgrad Med J; 1983; 59 Suppl 2():114-8. PubMed ID: 6889218
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension.
Levine JH; Ferdinand KC; Cargo P; Laine H; Lefkowitz M
Am J Hypertens; 1995 May; 8(5 Pt 1):494-9. PubMed ID: 7662226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
